Nanosonics Limited (NAN)

 NULL
   
  • 52 Week High: NULL
  • 52 Week Low: $2.63
  • Currency: Australian Dollars
  • Shares Issued: 299.96m
Select chart: 1 week | 1 month | 3 month | 6 month | 1 year
 

Current

1 week

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-25 187.79 11.75 3.42¢ 93.7 n/a n/a n/a 0.0%
30-Jun-26 207.05 19.26 4.80¢ 66.6 1.6 +41% n/a 0.0%
30-Jun-27 227.05 30.88 7.13¢ 44.9 0.9 +48% n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Forecast Ratios

Year Ending Revenue/Share Price/Revenue per Share
30-Jun-25 $0.63 5.11
30-Jun-26 $0.69 4.64
30-Jun-27 $0.76 4.23

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue ($m)
30-Jun-2025 188 188 188 192 192 220
30-Jun-2026 207 207 207 208 208 244
30-Jun-2027 227 227 227 n/a n/a n/a
 
Earnings
30-Jun-2025 3.42¢ 3.42¢ 3.42¢ 3.60¢ 3.62¢ 6.07¢
30-Jun-2026 4.80¢ 4.80¢ 4.80¢ 5.11¢ 5.20¢ 7.83¢
30-Jun-2027 7.13¢ 7.13¢ 7.13¢ n/a n/a n/a
 
Dividend
30-Jun-2025 n/a n/a n/a n/a n/a n/a
30-Jun-2026 n/a n/a n/a n/a n/a n/a
30-Jun-2027 n/a n/a n/a n/a n/a n/a
 
Recommendations
Strong Buy 1 1 1 1 1 1
Buy 2 2 2 2 2 2
Neutral 5 5 5 5 5 4
Sell 1 1 1 1 1 3
Strong Sell 1 1 1 1 1 1
No. of Brokers 10 10 10 10 10 11
 
Average Rec 5.25 5.25 5.25 5.25 5.25 4.77

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

NAN Market Data

Currency Australian Dollars
% Change 0.00 %
52 Week High NULL
52 Week Low $2.63
Shares Issued 299.96m

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 5
Sell 1
Strong Sell 1
Total 10
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page